Jashvik Capital's Futura Medtech Invests in Rivarp Medical

Futura Medtech Makes Strategic Investment in Rivarp Medical

Private equity firm Jashvik Capital announced on April 28 that its portfolio company, Futura Medtech, has made a strategic investment in Rivarp Medical, a Bengaluru-based manufacturer of medical devices and implants across orthopaedics, neurosurgery, and interventional cardiology. Financial terms of the transaction were not disclosed.

This deal represents the third investment under the Futura Medtech platform, advancing Jashvik Capital's strategy of building a scaled, multi-category medical devices business with strong domestic and global market access. The platform had previously invested in Dolphin Sutures in October 2024 and Suture Planet in July 2025.

Futura Medtech, founded in 2016, has developed a differentiated portfolio of products across high-growth therapeutic segments, supported by in-house manufacturing capabilities and international regulatory approvals, including EU MDR and US FDA certifications. The company distributes its products across India and international markets through a network of over 100 channel partners.

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

India's medical devices sector is witnessing sustained double-digit growth, driven by increasing healthcare penetration, a shift towards domestic manufacturing, and expanding export opportunities. Against this backdrop, Futura Medtech is being developed as an integrated platform combining product innovation, manufacturing scale, and distribution reach.

Jashvik Capital's investment in Rivarp Medical is expected to further equip its platform companies to bring a broader basket of innovative, high-quality products to surgeons and clinicians across India and international markets. Over the next two years, the firm plans to invest in more businesses to further strengthen its product basket and innovation pipeline and deepen its distribution reach.

Jashvik Capital's Focus on Healthcare and Consumer Sectors

Jashvik Capital is a mid-market private equity firm focused on investing in profitable growth businesses in healthcare and consumer sectors. The firm's latest investment in Rivarp Medical underscores its commitment to building a scaled, multi-category medical devices business with strong domestic and global market access.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Comparison of Investments Under Futura Medtech Platform

Note: The comparison table highlights the investments made by Futura Medtech under the Jashvik Capital platform.